Skip to main content
. 2020 May 2;9(5):1320. doi: 10.3390/jcm9051320

Figure 2.

Graft survival in the r-ATG and basiliximab groups. The two groups did not differ statistically.

Figure 2

Time (years) 0 1 2 3 4 5 6 7
Basiliximab survival rate 1 0.996 0.987 0.987 0.977 0.964 0.938 0.92
# at risk 231 229 223 207 179 140 92 43
r-ATG survival rate 1 1 1 1 0.971 0.971 0.971 0.971
# at risk 37 36 36 34 30 16 5 2